Nov 28, 2022 08:30AM
Apr 20, 2022 06:59AM
Apr 20, 2022 06:58AM
Apr 19, 2022 06:59AM
Apr 19, 2022 06:59AM
Apr 7, 2022 07:30AM
Dec 16, 2021 04:01PM Navidea Biopharmaceuticals Announces Launch of Phase 3 Clinical Trial in Rheumatoid Arthritis
Dec 15, 2021 05:46PM
Nov 10, 2021 04:01PM
Sep 27, 2021 07:30AM
Aug 11, 2021 04:26PM
Aug 11, 2021 04:01PM
Jul 15, 2021 07:32AM
Jul 15, 2021 07:30AM Navidea Biopharmaceuticals Announces End-of-Phase 2 Type B Meeting Request Granted by the FDA to Discuss Ongoing Clinical Program in Rheumatoid Arthritis
May 11, 2021 04:42PM
May 11, 2021 04:01PM
May 11, 2021 07:36AM
May 11, 2021 07:30AM
Apr 15, 2021 07:30AM
Mar 24, 2021 04:23PM
Mar 24, 2021 04:21PM Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 8, 2021 04:20PM
Feb 8, 2021 04:05PM
Nov 12, 2020 04:04PM
Nov 12, 2020 04:02PM
Aug 13, 2020 04:09PM
Aug 10, 2020 09:14AM
Aug 10, 2020 09:08AM Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership
Jun 15, 2020 08:00AM
Jun 9, 2020 07:30AM
Jun 3, 2020 07:31AM
Jun 3, 2020 07:30AM
May 21, 2020 04:32PM
May 21, 2020 04:30PM
Apr 22, 2020 07:35AM Navidea Biopharma (NAVB) Provides Statement Regarding COVID-19 Pandemic
Apr 22, 2020 07:30AM
Mar 31, 2020 07:30AM
Mar 20, 2020 07:06AM
Mar 20, 2020 07:00AM
Nov 7, 2019 07:30AM
Jun 24, 2019 07:46AM
Jun 17, 2019 05:16PM Navidea Biopharmaceuticals Announces Day and Time of SNMMI Presentation of Phase 1/2 Study Results and Enrollment Update on its Phase 2B Study
May 8, 2019 04:05PM
Apr 8, 2019 07:33AM
Apr 8, 2019 07:30AM
Apr 2, 2019 04:05PM
Mar 7, 2019 04:28PM
Mar 7, 2019 04:05PM
Dec 7, 2018 06:58AM Navidea Biopharma (NAVB) Reports Patent Extension for Lymphoseek
Dec 7, 2018 06:55AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All